The ETSI hosts the XLII Annual Congress of the Spanish Society of Biomedical Engineering (CASEIB 2024)

The Higher Technical School of Engineering of the University of Seville will host more than 300 experts between November 13 and 15 who will participate in the XLII Annual Congress of the Spanish Society of Biomedical Engineering (CASEIB 2024). 

This congress has been organized by the Spanish Society of Biomedical Engineering (SEIB) and the University of Seville, represented by the Biomedical Engineering and Signal and Communications Processing Research Groups, and has the collaboration of the Federation of Health Technology Companies (Fenin) and the Spanish node of the European Institute of Innovation & Technology in Health (EIT Health Spain). 

CASEIB is the main meeting place to establish collaborative links between research groups, industry and clinical and engineering professionals working in key areas for the digital transformation of health, such as, among others, medical signal and image processing, neuroengineering and rehabilitation engineering, telemedicine and connected health, health informatics, modeling and simulation of biomedical systems, surgical planning and simulation, biomedical instrumentation, biomechanics and biomaterials, medical robotics, or nanomedicine.

The motto chosen for this edition of CASEIB, "Enhancing multidisciplinary collaboration through Biomedical Engineering", reflects the importance of this scientific and professional discipline in uniting efforts towards the implementation of new healthcare paradigms, aimed at solving the challenges of sustainability and inclusivity that affect healthcare systems. 

The CASEIB 2024 scientific program reflects the current landscape of Biomedical Engineering, which is characterized, on the one hand, by the transformative power of health technologies on healthcare, on the other, by the emergence of digital twins, and on the third, by the maturity of artificial intelligence and additive biofabrication techniques. This is evidenced by the number of contributions presented on these topics.

Furthermore, the program includes 208 presentations, distributed across 18 regular sessions and three poster sessions, in addition to three special sessions addressing topics such as cardiovascular engineering, neurotechnologies, nanomedicine, and biomaterials. Also noteworthy are the two roundtables that are part of the program, in which leading figures from academia, industry, healthcare, hospital management, and innovation will discuss innovation in healthcare technology and the role of biomedical engineers in the hospital of the future. 

CASEIB 2024 also dedicates particular attention to students and young researchers, including sessions for finalists of the Prof. José María Ferrero Corral and SEIB-Fenin awards, and the presentation of the SEIB and EIT-Health Innovate & Inspire awards. The program is rounded out with two plenary lectures, given by Prof. Gregg Suaning of the University of Sydney and Dr. Ismael Muñoz, Secretary General for Healthcare Planning and Consumer Affairs of the Andalusian Regional Government's Ministry of Health and Consumer Affairs, who will speak on innovation in implanted medical devices and Andalusia's digital health strategy.

For three days, Seville will be an exceptional setting to share experiences and learn from the latest advances in Biomedical Engineering.